This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
BackgroundProteinuria is a risk factor for cardiovascular events, but its prognostic value for sudden cardiacarrest (SCA) in young individuals remains unproven. The influence of proteinuria on SCA was stronger in advanced chronic kidneydisease (stage 3 and stage 45).ConclusionsProteinuria
We have recently reported that chronic kidneydisease (CKD) is associated with higher likelihood of sudden cardiacarrest (SCA) presenting with non-shockable rhythms (NSR) (pulseless electrical activity/asystole), as opposed to shockable rhythms (ventricular fibrillation/pulseless ventricular tachycardia).
In this month's EM Quick Hits podcast: Justin Morgenstern on colchicine for COVID pneumonia, Victoria Myers on sodium bicarbonate in cardiacarrest, Brit Long on troponin in chronic kidneydisease, Michelle Klaiman on GHB overdose, Ian Walker on iloprost for frostbite, Sarah Reid on tips on avoiding patient and parent complaints.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
Patients with hyperkalemia had a higher frequency of diabetes mellitus, hypertension, chronic liver disease, acute kidney injury, chronic kidneydisease, end-stage renal disease, and acute encephalopathy (p<0.001).
Logistic regression was used to analyze the relationship between the treatment groups and hospital readmission within 90 days.Results:Only 517 AA met inclusion criteria and did not meet exclusion criteria, which included a history of valvular heart disease, hypertrophic or restrictive cardiomyopathy, active myocarditis, history of cardiacarrest, and (..)
He also had a history of chronic kidneydisease, stage III. Angio had shown some acute disease in the saphenous vein graft to the posterior descending artery off of the RCA. If cardiacarrest from hypokalemia is imminent (i.e., The mean serum potassium level was lower after resuscitation from cardiacarrest (3.6
Notes: Approved after initial rejection two years prior based on safety data from Japan, where the drug had been used since 2020 It can only be used in kidneydisease patients on dialysis for at least 3 months. The label includes a “black box” warning for CV risk due to blood clots.
But the full cohort of the CABANA trial did not show a significant reduction in the primary composite end point of death, disabling stroke, serious bleeding or cardiacarrest [7]. The study authors noted that lower than expected event rates and treatment crossovers could have affected the results of the trial. doi: 10.1001/jama.2019.0693.
mg experienced a 23% lower incidence of death from cardiovascular causes, resuscitated cardiacarrest, myocardial infarction, stroke, or urgent hospitalization for angina leading to coronary revascularization in a time-to-event analysis. 35 Overall, the magnitudes of benefit seen from colchicine, 0.5 12 Importantly, colchicine, 0.5
2] Curiously, ACLS does not include consideration of calcium in its bradycardia algorithm, which could have prevented the arrest and which along with the epi produced ROSC. HyperKalemia with CardiacArrest. Acute hyperkalemia in the emergency department: a summary from a KidneyDisease: Improving Global Outcomes conference.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content